Horizon Jumps Most Since 2019 After Disclosing Sale Talks (1)

Horizon Therapeutics Plc rose by the most in more than three years after the drug developer disclosed it’s in talks with a trio of potential suitors about a possible sale of the company.

Amgen Inc., Johnson & Johnson and Sanofi are separately engaged in preliminary discussions with Horizon, the company said in a statement on Tuesday. There’s no certainty that any of the talks will lead to an offer. Dublin-based Horizon makes drugs for rare autoimmune and inflammatory diseases.

Horizon soared 27% at 11:38 a.m. in New York and earlier was up 30%, the biggest intraday gain since February ...